Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

VITUS Post-Market Registry

NCT: NCT06832631 · ACTIVE_NOT_RECRUITING

NCT IDNCT06832631
StatusACTIVE_NOT_RECRUITING
Start Date2025-05-22
Completion2029-06
SponsorOrbusNeich (INDUSTRY)
First posted
Last updated

Brief Summary

To collect post marketing surveillance data on consecutive patients with peripheral arterial occlusive disease (PAOD) intended to be or treated by the VITUS peripheral drug-coated dilatation catheter when used according to the Instructions for Use and treating physician decision. Data will be collected in order to assess the long-term safety and performance of the VITUS peripheral drug-coated dilatation catheter in routine clinical practice.

Frequently Asked Questions

What is VITUS Post-Market Registry?

VITUS Post-Market Registry is a clinical trial registered under NCT06832631. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06832631?

The current status of NCT06832631 (VITUS Post-Market Registry) is: ACTIVE_NOT_RECRUITING.

When did VITUS Post-Market Registry start?

VITUS Post-Market Registry started on 2025-05-22.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.